Golembiewski Michael Joseph 4
4 · SEELOS THERAPEUTICS, INC. · Filed Mar 31, 2023
Insider Transaction Report
Form 4
Golembiewski Michael Joseph
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2023-03-30+677,701→ 677,701 totalExercise: $0.69Exp: 2033-03-30→ Common Stock (677,701 underlying) - Award
Stock Option (right to buy)
2023-03-30+88,030→ 88,030 totalExercise: $0.69From: 2023-03-30Exp: 2033-03-30→ Common Stock (88,030 underlying)
Footnotes (2)
- [F1]1/4th of the shares subject to the option shall vest on March 30, 2024, and 1/48th of the shares subject to the option shall vest monthly thereafter, subject to the Reporting Person's continued service to the Issuer through such vesting date.
- [F2]The Reporting Person voluntarily elected to be paid 35% of his 2022 annual cash bonus in the form of an option to purchase shares of common stock of the Issuer.